https://doi.org/10.4081/monaldi.2022.2414
Varicella zoster virus and cardiovascular diseases
Submitted: August 19, 2022
Accepted: September 3, 2022
Published: September 21, 2022
Accepted: September 3, 2022
Abstract Views: 2123
PDF: 819
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Varicella zoster virus (VZV) is a Herpesviridae family double-stranded DNA virus that only affects humans. The first clinical manifestation appears to be varicella, typical of childhood. VZV, on the other hand, becomes latent in ganglion neurons throughout the neuroaxis after primary infection. The VZV reactivates and travels along peripheral nerve fibers in the elderly and immunocompromised individuals, resulting in Zoster. It can, however, spread centrally and infect cerebral and extracranial arteries, resulting in vasculopathy, which can lead to transient ischemic attacks, strokes, aneurysms, cavernous sinus thrombosis, giant cell arteritis, and granulomatous aortitis. Although the mechanisms of virus-induced pathological vascular remodeling are not fully understood, recent research indicates that inflammation and dysregulation of ligand-1 programmed death play a significant role. Few studies, on the other hand, have looked into the role of VZV in cardiovascular disease. As a result, the purpose of this review is to examine the relationship between VZV and cardiovascular disease, the efficacy of the vaccine as a protective mechanism, and the target population of heart disease patients who could benefit from vaccination.
Badani H, White T, Schulick N, et al. Frequency of varicella zoster virus DNA in human adrenal glands. J Neurovirol 2016;22:400-2.
DOI: https://doi.org/10.1007/s13365-016-0425-8
Baudouin E, Lantuejoul P. [Les troublecas moteurs dans le zona].[Article in French]. Gaz Hop 1919;92:1293.
Braun KP, Bulder MM, Chabrier S, et al. The course and outcome of unilateral intracranial arteriopathy in 79 children with ischaemic stroke. Brain 2009;132:544–57.
DOI: https://doi.org/10.1093/brain/awn313
Breuer J, Pacou M, Gauthier A, Brown MM. Herpes zoster as a risk factor for stroke and TIA: a retrospective cohort study in the UK. Neurology 2014;82:206-12.
DOI: https://doi.org/10.1212/WNL.0000000000000038
Burbelo PD, Browne SK, Sampaio EP, et al. Anti- cytokine autoantibodies are associated with opportunistic infection in patients with thymic neoplasia. Blood 2010;116:4848–58.
DOI: https://doi.org/10.1182/blood-2010-05-286161
Nagel MA, Bubak AN. Varicella zoster virus vasculopathy. J Infect Dis 2018;218:S107-12.
DOI: https://doi.org/10.1093/infdis/jiy425
Nagel MA, Jones D, Wyborny A. Varicella zoster virus vasculopathy: The expanding clinical spectrum and pathogenesis. J Neuroimmunol 2017;308:112-7.
DOI: https://doi.org/10.1016/j.jneuroim.2017.03.014
Cope S, Jones AT. Hemiplegia complicating ophthalmic zoster. Lancet 1954;267:898-9.
DOI: https://doi.org/10.1016/S0140-6736(54)92614-8
Hashemi N, Zhang J, Volpi J, et al. A pox upon your house. Surv Ophthalmol 2013;58:640–3.
DOI: https://doi.org/10.1016/j.survophthal.2012.05.005
Filloux F, Townsend J. Herpes zoster ophthalmicus with ipsilateral cerebellar infarction. Neurology 1985;35:1531-2.
DOI: https://doi.org/10.1212/WNL.35.10.1531-a
Verghese A, Sugar AM. Herpes zoster ophthalmicus and granulomatous angiitis. An ill-appreciated cause of stroke. J Am Geriatr Soc 1986;34:309-12.
DOI: https://doi.org/10.1111/j.1532-5415.1986.tb04227.x
Liu X, Guan Y, Hou L, et al. The short- and long-term risk of stroke after herpes zoster: a meta-analysis. PLoS One 2016;11:e0165203.
DOI: https://doi.org/10.1371/journal.pone.0165203
Yang SY, Li HX, Yi XH, et al. Risk of stroke in patients with herpes zoster: a systematic review and meta-analysis. J Stroke Cerebrovasc Dis 2017;26:301–7.
DOI: https://doi.org/10.1016/j.jstrokecerebrovasdis.2016.09.021
Uthman I, Taher A, Khalil I. Hughes syndrome associated with varicella infection. Rheumatol Int 2001;20:167–8.
DOI: https://doi.org/10.1007/s002960000086
Peyton BD, Cutler BS, Stewart FM. et al. Spontaneous tibial artery thrombosis associated with varicella pneumonia and free protein S deficiency. J Vasc Surg 1998;27:563–7.
DOI: https://doi.org/10.1016/S0741-5214(98)70335-0
Bodensteiner JB, Hille MR, Riggs JE. Clinical features of vascular thrombosis following varicella. Am J Dis Child 1992;146:100–2.
DOI: https://doi.org/10.1001/archpedi.1992.02160130102029
Erskine N, Tran H, Levin L, et al. A systematic review and meta-analysis on herpes zoster and the risk of cardiac and cerebrovascular events. PLoS One 2017;12:e0181565.
DOI: https://doi.org/10.1371/journal.pone.0181565
Seo HM, Cha MJ, Han JH, et al. Reciprocal relationship between herpes zoster and cardiovascular diseases: A nationwide population-based case-control study in Korea. J Dermatol 2018;45:1312-8.
DOI: https://doi.org/10.1111/1346-8138.14597
Warren-Gash C. Herpes zoster: epidemiological links with stroke and myocardial infarction. J Infect Dis 2018;218:S102-6.
DOI: https://doi.org/10.1093/infdis/jiy385
Wang CC, Lin CL, Chang YJ, et al. Herpes zoster infection associated with acute coronary syndrome: a population-based retrospective cohort study. Br J Dermatol 2014;170:1122-9.
DOI: https://doi.org/10.1111/bjd.12768
Wu P-H, Chuang Y-S, Lin Y-T. Does Herpes Zooster Increase the risk of stroke and myocardial infarction? A comprehensive review. J Clin Med 2019;8:547.
DOI: https://doi.org/10.3390/jcm8040547
Kimberlin DW, Whitley RJ. Varicella-zoster vaccine for the prevention of herpes zoster. N Engl J Med 2007;356:1338-43.
DOI: https://doi.org/10.1056/NEJMct066061
U.S. Food and Drug Administration. Zostavax. 2006 (package insert). Accessed March 5, 2007. Available from: https://www.fda.gov/media/82524/download
Levin MJ, Murray M, Rotbart HA, et al. Immune response of elderly individuals to a live attenuated varicella vaccine. J Infect Dis 1992;166:253-9.
DOI: https://doi.org/10.1093/infdis/166.2.253
Schmader KE, Levin MJ, Gnann JW, Jr, et al. Efficacy, safety and tolerability of herpes zoster vaccine in persons aged 50-59 years. Clin Infect Dis 2012;54:922-8
DOI: https://doi.org/10.1093/cid/cir970
James SF, Chahine EB, Sucher AJ, Hanna C. Shingrix: The new adjuvanted recombinant herpes zoster vaccine. Ann Pharmacother 2018;52:673-80.
DOI: https://doi.org/10.1177/1060028018758431
European Medicines Agency [Internet]. [Shingrix. Riassunto delle caratteristiche del prodotto].[in Italian]. Available from: https://www.ema.europa.eu/en/documents/product-information/shingrix-epar-product-information_it.pdf
Brisson M, Edmunds WJ, Law B, et al. Epidemiology of varicella zoster infection in Canada and the United Kingdom. Epidemiol Infect 2011;127:305–14.
DOI: https://doi.org/10.1017/S0950268801005921
Okamoto S, Hata A, Sadaoka K, et al. Comparison of varicella zoster virus specific immunity to patients with diabetes mellitus and healthy individuals. J Infect Dis 2009;200:1606–10.
DOI: https://doi.org/10.1086/644646
Heymann AD, Chodick G, Karpati T, et al. Diabetes as a risk factor for herpes zoster infection: results of a population-based study in Israel. Infection 2008;36:226–30.
DOI: https://doi.org/10.1007/s15010-007-6347-x
Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005;352:2271-84.
DOI: https://doi.org/10.1056/NEJMoa051016
Arvin AM. Varicella-zoster virus. Clin Microbiol Rev 1996;9:361–81.
DOI: https://doi.org/10.1128/CMR.9.3.361
Levin MJ, Smith JG, Kaufhold RM, et al. Decline in varicella-zoster virus (VZV)–specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine. J Infect Dis 2003;188:1336–44.
DOI: https://doi.org/10.1086/379048
Levin MJ, Oxman MN, Zhang JH, et al. Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine. J Infect Dis 2008;197:825–35.
DOI: https://doi.org/10.1086/528696
Yang Q, ChangA, Tong X, Merritt R. Herpes zoster vaccine live and risk of stroke among medicare beneficiaries. Stroke 2021;52:1712-21.
DOI: https://doi.org/10.1161/STROKEAHA.120.032788
Ministero della Salute. [Piano Nazionale di Prevenzione Vaccinale 2017-2019.[in Italian]. Available from: https://www.salute.gov.it/portale/vaccinazioni/dettaglioPubblicazioniVaccinazioni.jsp?lingua=italiano&id=2571
Regione Lombardia. [Le vaccinazioni offerte gratuitamente in Lombardia].[in Italian]. Available from: https://www.wikivaccini.regione.lombardia.it/wps/portal/site/wikivaccini/DettaglioRedazionale/le-vaccinazioni-quali/vaccini
Wu P-H, Lin Y-T, Lin C-Y, et al. A nationwide population-based cohort study to identify the correlation between heart failure and the subsequent risk of herpes zoster. BMC Infect Dis 2015;17:17.
DOI: https://doi.org/10.1186/s12879-015-0747-9
Verschoor CP, Lelic A, Parsons R, et al. Serum C-reactive protein and congestive heart failure as significant predictors of herpes zoster vaccine response in elderly nursing home residents. J Infect Dis 2017;216:191-7.
DOI: https://doi.org/10.1093/infdis/jix257
Cool CD, Voelkel NF, Bull T. Viral infection and pulmonary hypertension: is there an association? Expert Rev Respir Med 2011;5:207-16.
DOI: https://doi.org/10.1586/ers.11.17
Cha M-J, Seo H-M, Choi E-K, et al. Increased risk of atrial fibrillation in the early period after herpes zoster infection: a nationwide population-based case-control study. J Korean Med Sci 2018;33:e160.
DOI: https://doi.org/10.3346/jkms.2018.33.e160
How to Cite
Cersosimo, Angelica, Mauro Riccardi, Ludovica Amore, Giuliana Cimino, Gianmarco Arabia, Marco Metra, and Enrico Vizzardi. 2022. “Varicella Zoster Virus and Cardiovascular Diseases”. Monaldi Archives for Chest Disease 93 (2). https://doi.org/10.4081/monaldi.2022.2414.
Copyright (c) 2022 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Michele Vitacca, Marta Lazzeri, Enrico Guffanti, Pamela Frigerio, Francesco D’Abrosca, Silvia Gianola, Mauro Carone, Mara Paneroni, Piero Ceriana, Franco Pasqua, Paolo Banfi, Francesco Gigliotti, Carla Simonelli, Serena Cirio, Veronica Rossi, Chiara G. Beccaluva, Mariangela Retucci, Martina Santambrogio, Andrea Lanza, Francesca Gallo, Alessia Fumagalli, Marco Mantero, Greta Castellini, Mariaconsiglia Calabrese, Giorgio Castellana, Eleonora Volpato, Marina Ciriello, Marina Garofano, Enrico Clini, Nicolino Ambrosino, on behalf of AIPO, ARIR, SIP, AIFI and SIFIR, An Italian consensus on pulmonary rehabilitation in COVID-19 patients recovering from acute respiratory failure: results of a Delphi process , Monaldi Archives for Chest Disease: Vol. 90 No. 2 (2020)
- Gian Francesco Mureddu, Cesare Greco, Stefano Rosato, Paola D'Errigo, Leonardo De Luca, Gabriella Badoni, Pompilio Faggiano, Fulvia Seccareccia, High thrombotic risk increases adverse clinical events up to 5 years after acute myocardial infarction. A nationwide retrospective cohort study , Monaldi Archives for Chest Disease: Vol. 89 No. 3 (2019)
- Marco Umberto Scaramozzino, Maurizia Festa, Guido Levi, Ubaldo Romeo Plastina, Giovanni Sapone, Correlation between gastroesophageal reflux disease lung volumes and exacerbation of bronchial asthma: Italian pilot observational retrospective study GERDAS , Monaldi Archives for Chest Disease: Vol. 94 No. 2 (2024)
- Fabrizio Scafa, Alessia Gallozzi, Giovanni Forni, Stefano M. Candura, Work resumption after invasive heart procedures, rehabilitation and ergonomic evaluation: from the hospital to the workplace , Monaldi Archives for Chest Disease: Vol. 94 No. 2 (2024)
- Murali Mupparapu, Rajesh Venkataram, Nandakishore Baikunje, Ivor D'sa, Chandramouli Mandya Thimmaiah, Assessment of left ventricular function in subjects with chronic obstructive pulmonary disease , Monaldi Archives for Chest Disease: Early Access
- Ricardo Alves Pinto, Catarina Amaral Marques, Tânia Proença, Miguel Martins Carvalho, Cristina Cruz, Filipe Macedo, The world upside down – after 20 years of follow-up of dextro-transposition of the great arteries , Monaldi Archives for Chest Disease: Vol. 94 No. 1 (2024)
- Nishant Kumar Chauhan, Ashish Agarwal, Naveen Dutt, Taruna Yadav, Rishabh Kochar, Pulmonary embolism and gastric bleed with disseminated mucormycosis - treading dangerous waters , Monaldi Archives for Chest Disease: Vol. 93 No. 3 (2023)
- Luigi Pinto, Pietro Schino, Michele Bitetto, Ersilia Tedeschi, Michele Maiellari, Giancarlo De Leo, Elena Ludovico, Giovanni Larizza, Franco Mastroianni, Fibrotic outcomes from SARS-CoV-2 virus interstitial pneumonia , Monaldi Archives for Chest Disease: Early Access
- Devika Tayal, Prerna Jain, Mamta Bhardwaj, Amit Sharma, Diabetes mellitus in acute exacerbation of chronic obstructive pulmonary disease – the tip of the iceberg , Monaldi Archives for Chest Disease: Early Access
- Hazuki Fujimoto, Yohei Kanzawa, Hidemine Senba, Tetsuo Washio, Yukiko Kato, Kei Kawano, Shimpei Mizuki, Jun Ohnishi, Takahiro Nakajima, Naoto Ishimaru, Saori Kinami, Hemophagocytic syndrome in a patient with long-term stable pulmonary sarcoidosis with progressive spleen and bone marrow lesion , Monaldi Archives for Chest Disease: Vol. 93 No. 4 (2023)
<< < 36 37 38 39 40 41 42 43 44 45 > >>
You may also start an advanced similarity search for this article.
